Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
917,622
-
Share change
-
+917,622
-
Total reported value
-
$50,276,665
-
Price per share
-
$54.71
-
Number of holders
-
67
-
Value change
-
+$50,276,668
-
Number of buys
-
67
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q2 2018
As of 30 Jun 2018,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
917,622 shares.
The largest 10 holders included
MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, BANK OF AMERICA CORP /DE/, LPL Financial LLC, CUE FINANCIAL GROUP, INC., Abbot Financial Management, Inc., US BANCORP \DE\, and People's United Financial, Inc..
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.